Tuesday, April 17, 2012
press release: Consumer Activity on Social Media Sites Dwarfs That of Healthcare Companies, Finds New PwC Study on Social Media in Healthcare
Consumer Activity on Social Media Sites Dwarfs That of Healthcare Companies, Finds New PwC Study on Social Media in Healthcare
NEW YORK, April 17, 2012 /PRNewswire/ -- Social media is changing the nature of healthcare interaction, and health organizations that ignore this virtual environment may be missing opportunities to engage consumers, according to a new report by the Health Research Institute (HRI) at PwC US entitled, "Social media likes healthcare: From marketing to social business." The report found that social media activity by hospitals, health insurers and pharmaceutical companies is miniscule compared to the activity on community sites......
The consumer survey found:
- One-third of consumers now use social media sites such as Facebook, Twitter, YouTube and online forums for health-related matters, including seeking medical information, tracking and sharing symptoms, and broadcasting how they feel about doctors, drugs, treatments, medical devices and health plans.
- Four in 10 consumers say they have used social media to find health-related consumer reviews (e.g. of treatments or physicians); one in three have sought information related to other patients' experiences with their disease; one in four have "posted" about their health experience; and one in five have joined a health forum or community.
- When asked how information found through social media would affect their health decisions, 45 percent of consumers said it would affect their decision to get a second opinion; 41 percent said it would affect their choice of a specific doctor, hospital or medical facility; 34 percent said it would affect their decision about taking a certain medication; and 32 percent said it would affect their choice of a health insurance plan.
- While 72 percent of consumers said they would appreciate assistance in scheduling doctor appointments through social media channels, nearly half said they would expect a response within a few hours.
- As is the case more broadly, young adults are leading the social media healthcare charge. More than 80 percent of individuals between the ages of 18 and 24 said they were likely to share health information through social media channels and nearly 90 percent said they would trust information they found there. By comparison, less than half (45 percent) of individuals between the ages of 45 and 64 said they were likely to share health information via social media.
Diffusion-weighted Imaging Study in Cancer of the Ovary - Full Text View - ClinicalTrials.gov
Diffusion-weighted Imaging Study in Cancer of the Ovary - Full Text View - ClinicalTrials.gov
Diffusion-weighted Imaging Study in Cancer of the Ovary (DISCOVAR)
This study is not yet open for participant recruitment.
Verified March 2012 by Institute of Cancer Research, United Kingdom
First Received on November 18, 2011.
Last Updated on March 30, 2012
History of Changes
| Sponsor: | Institute of Cancer Research, United Kingdom |
|---|---|
| Collaborators: | Cancer Research UK Royal Marsden NHS Foundation Trust Cambridge University Hospitals NHS Foundation Trust Imperial College Healthcare NHS Trust Northumbria Healthcare NHS Foundation Trust |
| Information provided by (Responsible Party): | NdeSouza, Institute of Cancer Research, United Kingdom |
| ClinicalTrials.gov Identifier: | NCT01505829 |
Purpose
This
project seeks to develop a quantitative imaging biomarker for evaluating
and monitoring treatment response in ovarian cancer metastases and
assess its potential in monitoring treatment response. This will involve
standardising DW-MRI for the abdomen and pelvis across multiple centres
and platforms, assessing reproducibility of the measurement in patients
planned for neoadjuvant chemotherapy and assessing its utility as an
early response biomarker in patients with platinum-sensitive relapse due
to receive therapy with carboplatin. Scanning measurements will be
correlated with histopathological markers in tumour samples in order to
link the biomarker with response mechanisms.
| Condition |
|---|
| Ovarian Cancer Peritoneal Metastases |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Assessing Treatment Response of Peritoneal Metastases in Ovarian Cancer Using Diffusion Weighted Magnetic Resonance Imaging. |
financial news: ImmunoGen Says IND For Anticancer Compound IMGN853 Is Now Active
ImmunoGen Says IND For Anticancer Compound IMGN853 Is Now Active
(RTTNews.com) - ImmunoGen, Inc. (IMGN) announced that the Investigational New Drug, or IND, application for its IMGN853 product candidate is now active. IMGN853 is a potential new therapeutic for ovarian cancer, non-small cell lung cancer and other epithelial malignancies which over-express folate receptor 1, or FOLR1.
The company expects Phase I evaluation of IMGN853 to commence in the middle of 2012.....
Health Imaging: Uptick in colorectal cancer among under-50 crowd poses questions for researchers (Lynch Syndrome....)
Uptick in colorectal cancer among under-50 crowd poses questions for researchers
....Whatever the cause, the rate of colorectal cancer in young adults has increased to the point where nearly 10 percent of new diagnoses are in patients younger than 50. Most of these patients were diagnosed in their forties, but the disease has been found in patients in their twenties and thirties.......Another troubling recent finding is that when colorectal cancers are diagnosed in younger patients, they are more likely to be at an advanced stage of the disease. A study published Feb. 13 online in Archives of Internal Medicine found 63 percent of colon cancers and 57 percent of rectal cancers are stage III or IV at diagnosis......“The important thing for radiologists would be the notion that certain individuals, because of their age, may be denied radiology procedures by insurance companies,” she said.......
open access: What do surgical trainees think about patient safety culture, and is this different from their consultants?
What do surgical trainees think about patient safety culture, and is this different from their consultants?
Abstract
Introduction Little is
known about the patient safety culture within surgical departments in
UK hospitals. What has been done to date
is to survey only permanent senior staff opinion
of the safety culture in their institution. This study surveyed both
consultant
and trainee views on perceived patient safety
and compared the results between these two groups.
Material and methods
The previously validated Team Work and Safety Climate Questionnaire was
configured in Survey Monkey format and sent to all
surgical trainees and consultant surgeons in the
South West Strategic Health Authority. Two reminders were sent to
achieve
as high a return rate as possible.
Results Two hundred
and ninety-six replies were received. Forty-four percent of trainees and
30% of consultants responded to the
survey. Consultants consistently rated a higher
safety culture than surgical trainees. Only 2.9% of trainees believe
their
patient safety concerns would be acted upon by
hospital management. There is notable variation in perceived patient
safety
culture between hospitals.
Conclusion This study
has suggested that the patient safety culture in hospitals, within a
Strategic Health Authority, is variable and
sub-optimal when viewed by surgical trainees and
their consultants. This study also provides some evidence that the
perception
of patient safety in an organization varies
according to clinical experience. As trainees deliver a great deal of
clinical
care, surveys of safety culture should include
this group. As perceived patient safety culture is correlated to
clinical outcomes,
validated safety surveys might form part of the
assessment of a hospital's performance, along with outcome and patient
satisfaction.
Introduction
Medical errors are a major cause of mortality and morbidity. The National Patient Safety Agency (NPSA) estimates that 10% of all hospital admissions suffer an adverse event defined as a medical error that results in harm to the patient. One percent of all admissions die as a result of an adverse event. In practice this means that in England and Wales 300,000 adverse events and 30,000 deaths are recorded every year. This figure of 30,000 deaths a year is a greater number of deaths than the combined annual mortality from colorectal, prostate and breast cancer.1 Even these striking figures may be underestimating the extent of the problem because recent studies in the surgical literature2 indicate the adverse event rate could even be as high as 20%...........Cancer Prevention Research: Does Vitamin E Prevent or Promote Cancer?
Abstract
The cancer preventive activity of vitamin E
has been suggested by many epidemiologic studies. However, several
recent large-scale
human trials with α-tocopherol, the most commonly
recognized and used form of vitamin E, failed to show a cancer
preventive
effect. The recently finished follow-up of the
Selenium and Vitamin E Cancer Prevention Trial (SELECT) even showed
higher
prostate cancer incidence in subjects who took
α-tocopherol supplementation. The scientific community and the general
public
are faced with a question: “Does vitamin E prevent
or promote cancer?” Our recent results in animal models have shown the
cancer preventive activity of γ- and δ-tocopherols
as well as a naturally occurring mixture of tocopherols, and the lack of
cancer preventive activity by α-tocopherol. On the
basis of these results as well as information from the literature, we
suggest
that vitamin E, as ingested in the diet or in
supplements that are rich in γ- and δ-tocopherols, is cancer preventive;
whereas
supplementation with high doses of α-tocopherol is
not. Cancer Prev Res; 1–5. ©2012 AACR.
Subscribe to:
Posts
(
Atom
)
Posts
